Management of Statin Intolerance in 2018: Still More Questions Than Answers
Peter P. Tóth(University of Debrecen), Maciej Banach(John Paul II Catholic University of Lublin), Dragana Nikolić(Neurosciences Institute), Rosaria Vincenza Giglio(University of Palermo), Giuseppa Castellino(University of Palermo), Manfredi Rizzo(University of Palermo), Angelo Maria Patti(University of Palermo)
Cited by 187
Related Papers
Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000–2021: a systematic analysis from the Global Burden of Disease Study 2021
|The Lancet Haematology|2023|674
Complications of Diabetes 2017
|Journal of Diabetes Research|2018|644
Global, regional, and national burden of rheumatoid arthritis, 1990–2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021
|The Lancet Rheumatology|2023|584
Lipid levels in polycystic ovary syndrome: systematic review and meta-analysis
|Fertility and Sterility|2011|454
Efficacy and Safety of Bempedoic Acid in Patients With Hypercholesterolemia and Statin Intolerance
|Journal of the American Heart Association|2019|431